Harvard Bioscience to Showcase at Benchmark’s Investment Conference

HOLLISTON, Mass. - With the investment community looking forward to the year-end updates, Harvard Bioscience, Inc. HBIO, a prominent player in the life science research tools sector, is poised to partake in the upcoming Benchmark Company's 12th Annual Discovery One-on-One Investor Conference. This event is scheduled for Thursday, December 7th, 2023, and will be hosted at the historically rich venue of the New York Athletic Club in the heart of New York City.

An Insight into Harvard Bioscience, Inc.

Stepping into the investor spotlight, HBIO is an esteemed organization headquartered in Holliston, Massachusetts. It stands out as a developer, manufacturer, and provider of essential technologies, products, and services that are vital for fundamental research, discovery, and the preclinical stages of drug development. The impending conference will serve as a platform for Harvard Bioscience to potentially expand its investor base and articulate its strategic business initiatives.

Understanding Science Applications International Corporation

Alongside HBIO, Science Applications International Corporation SAIC will also capture the attention of the financial and investment communities. As a leading provider of technical, engineering, and business information technology (IT) services positioned in Reston, Virginia, SAIC primarily operates within the United States, delivering support and solutions to complex IT challenges.

The Significance of the Investor Conference

The Benchmark Company's Discovery One-on-One Investor Conference stands as a crucial event, assembling a variety of companies and investors. It emphasizes personalized meetings, providing investors a unique opportunity to engage with senior management of participating companies like HBIO and gain deeper insights into their business prospects and performance strategies.

HarvardBioscience, InvestorConference, Benchmark